174953-18-5

Upstream product

• 98-88-4 benzoyl chloride 

Downstream Products

• 174811-16-6 methyl 6-O-[3,4,6-tri-O-benzoyl-2-(benzoyloxyimino)-2-deoxy-α-D-lyxo-hexopyranosyl]-2,3,4-tri-O-benzyl-α-D-glucopyranoside 
• 174811-18-8 O³-[3,4,6-tri-O-benzoyl-2-(benzoyloxyimino)-2-deoxy-α-D-lyxo-hexopyranosyl]-N-benzyloxycarbonyl-L-serine benzyl ester 
• 174811-14-4 6-O-[3,4,6-tri-O-benzoyl-2-(benzoyloxyimino)-2-deoxy-α-D-lyxo-hexopyranosyl]-1,2:3,4-di-O-isopropylidene-α-D-galactopyranose 
• 174811-13-3 3,4,6-tri-O-benzoyl-2-(benzoyloxyimino)-2-deoxy-β-lyxo-hexopyranosyl N,N-diethyldithiocarbonate 
• 1054662-10-0 C₃₉H₄₃NO₁₃ 
• 174811-12-2 3,4,6-tri-O-benzoyl-2-(benzoyloxyimino)-2-deoxy-α-lyxo-hexopyranosyl bromide 

Relevant academic research and scientific papers

Synthesis and utility of 2-(benzoyloxyimino)-2-deoxy-α-D-lyxo-hexopyranosyl bromide as a novel α-D-talosaminide building block

A novel α-D-talosaminyl donor, 2-(benzoyloxyimino)-2-deoxy-α-D-lyxo-hexopyranosyl bromide has been synthesized in a total yield of 32% over 6 steps from D-galactose. The utility of the donor was evaluated for the elaboration of α-D-TalNAc-(1→6)-α-D-Gal, α-D-TalNAc-(1→6)-α-D-Glc, and α-D-TalNAc-(1→3)-L-serine derivatives by a simple 3-step sequence, comprising α-selective glycosylation of appropriately protected acceptors of D-galactose, D-glucose, and L-serine, talo-selective hydroboration of the oxyimino function to an amino group, and N-acetylation.